2. Search Result
Search Result
Results for "

NKL-22

" in MCE Product Catalog:
Targets Recommended:
Cat. No. Product Name Target Research Areas
  • HY-100384
    NKL 22

    		HDAC Neurological Disease
    NKL 22 (compound 4b) is a potent and selective inhibitor of histone deacetylases (HDAC), with an IC50 of 199 and 69 nM for HDAC1 and HDAC3, respectively. NKL 22 exhibits selectivity over HDAC2/4/5/7/8 (IC50≥1.59 μM). NKL 22 ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.